Key Financial Data Of Reporting Company

Astellas Pharma Inc. - Filing #7551605

Concept As at
2023-06-30
As at
2023-03-31
As at
2022-06-30
Key financial data of reporting company
Business results of reporting company
Cash and cash equivalents
561,487,000,000 JPY
376,840,000,000 JPY
313,013,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.